Trials / Completed
CompletedNCT02472314
Exparel for Postoperative Pain Management in Shoulder Surgery
A Novel Application of Exparel for Postoperative Pain Management in Shoulder Arthroplasty and Humerus Fracture Fixation
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Wayne State University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the effect of liposomal Bupivacaine infiltration into the shoulder to continues nerve block with Bupivacaine on postoperative pain control and functional outcomes.
Detailed description
liposomal bupivacaine analgesia will provide improved postoperative pain control, reduction in amount of opioid supplementation, decreased complications and faster return to function compared to current standard of care pain management for patients undergoing shoulder arthroplasty and shoulder surgery for proximal humerus fractures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 1.3% Liposomal Bupivacaine | local tissue infiltration of Liposomal Bupivacaine during surgery |
| DRUG | 0.125% Bupivacaine | Continues nerve block with Bupivacaine during surgery and postoperatively |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2017-05-01
- Completion
- 2017-05-01
- First posted
- 2015-06-15
- Last updated
- 2023-12-29
- Results posted
- 2019-04-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02472314. Inclusion in this directory is not an endorsement.